Current status and prospects of new radionuclides and radiopharmaceuticals for cardiovascular nuclear medicine
- 30 April 1987
- journal article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 17 (2) , 145-181
- https://doi.org/10.1016/s0001-2998(87)80019-3
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced Rubidium-82Journal of the American College of Cardiology, 1986
- Regional myocardial and organ blood flow after myocardial infarction: application of the microsphere principle in man.Circulation, 1986
- Validation of quantitation of regional myocardial blood flow in vivo with 11C-labeled human albumin microspheres and positron emission tomography.Circulation, 1984
- Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilationThe American Journal of Cardiology, 1982
- N-13 ammonia as an indicator of myocardial blood flow.Circulation, 1981
- In vivo quantitation of regional myocardial blood flow by positron-emission computed tomography.Circulation, 1981
- The dependence of accumulation of 13NH3 by myocardium on metabolic factors and its implications for quantitative assessment of perfusion.Circulation, 1980
- Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomographyThe American Journal of Cardiology, 1979
- Noninvasive assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatationThe American Journal of Cardiology, 1979
- Blood flow measurements with radionuclide-labeled particlesProgress in Cardiovascular Diseases, 1977